Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Essiac (ESIAK) Versus Placebo to Improve Quality of Life in Transition in Women With Breast or Ovarian Cancer.

This study has been terminated.
Sponsor:
Information provided by:
Women and Infants Hospital of Rhode Island
ClinicalTrials.gov Identifier:
NCT00287482
First received: February 3, 2006
Last updated: February 8, 2007
Last verified: February 2007
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: July 2007
  Estimated Primary Completion Date: No date given